A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): Impact of radiation and cisplatin intensity on outcome.

被引：30
|
作者：
Ang, K.
Zhang, Q.
Wheeler, R. H.
Rosenthal, D. I.
Nguyen-Tan, F.
Kim, H.
Lu, C.
Axelrod, R. S.
Silverman, C. I.
Weber, R. S.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] RTOG Stat Ctr, Philadelphia, PA USA
[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[4] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[5] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[6] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[7] Univ Louisville, Louisville, KY 40292 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.5507
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5507
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Comparison of Cisplatin Versus Cetuximab With Intensity Modulated Radiation Therapy in Locally Advanced Squamous Cell Carcinomas of Head and Neck: Toxicity, Patterns of Failure, and Survival Analysis
    Kanakamedala, M. R.
    Giri, S. P.
    Abraham, R. S.
    Albert, A. A.
    Vijayakumar, S.
    Hamilton, R. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S565 - S565
  • [42] A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
    Fu, KK
    Pajak, TF
    Trotti, A
    Jones, CU
    Spencer, SA
    Phillips, TL
    Garden, AS
    Ridge, JA
    Cooper, JS
    Ang, KK
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01): : 7 - 16
  • [43] Phase 2 Study of Docetaxel, Cisplatin, and Concurrent Radiation for Technically Resectable Stage III-IV Squamous Cell Carcinoma of the Head and Neck
    Puthiyottil, Sanudev Sadanandan Vadakke
    Bhattacharyya, Tapesh
    Purushothaman, Kiran
    Muttath, Geetha
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (02): : 469 - 470
  • [44] Phase 2 Study of Docetaxel, Cisplatin, and Concurrent Radiation for Technically Resectable Stage III-IV Squamous Cell Carcinoma of the Head and Neck
    Inohara, Hidenori
    Takenaka, Yukinori
    Yoshii, Tadashi
    Nakahara, Susumu
    Yamamoto, Yoshifumi
    Tomiyama, Yoichiro
    Seo, Yuji
    Isohashi, Fumiaki
    Suzuki, Osamu
    Yoshioka, Yasuo
    Sumida, Iori
    Ogawa, Kazuhiko
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 91 (05): : 934 - 941
  • [45] Early Postoperative Paclitaxel Followed by Concurrent Paclitaxel and Cisplatin With Radiation Therapy for Patients With Resected High-Risk Head and Neck Squamous Cell Carcinoma: Report of the Phase II Trial RTOG 0024
    Rosenthal, David I.
    Harris, Jonathan
    Forastiere, Arlene A.
    Weber, Randal S.
    Ridge, John A.
    Myers, Jeffrey N.
    Garden, Adam S.
    Kuettel, Michael R.
    Sidhu, Kulbir
    Schultz, Christopher J.
    Trotti, Andy
    Ang, K. Kian
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : 4727 - 4732
  • [46] Cetuximab and Radiation Therapy Versus Cisplatin and Radiation Therapy for Locally Advanced Head and Neck Cancer: Long-Term Survival and Toxicity Outcomes of a Randomized Phase 2 Trial
    Maddalo, Marta
    Borghetti, Paolo
    Tomasini, Davide
    Corvo, Renzo
    Bonomo, Pierluigi
    Petrucci, Alessia
    Paiar, Fabiola
    Lastrucci, Luciana
    Bonu, Marco Lorenzo
    Greco, Diana
    Costa, Loredana
    Pegurri, Ludovica
    Triggiani, Luca
    Belgioia, Liliana
    Desideri, Isacco
    Grisanti, Salvatore
    Buglione, Michela
    Magrini, Stefano Maria
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 107 (03): : 469 - 477
  • [47] A Phase 2 Trial of Induction nab-Paclitaxel and Cetuximab Given With Cisplatin and 5-Fluorouracil Followed by Concurrent Cisplatin and Radiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Adkins, Douglas
    Ley, Jessica
    Trinkaus, Kathryn
    Thorstad, Wade
    Lewis, James, Jr.
    Wildes, Tanya
    Siegel, Barry A.
    Dehdashti, Farrokh
    Gay, Hiram
    Mehan, Paul
    Nussenbaum, Brian
    CANCER, 2013, 119 (04) : 766 - 773
  • [48] FAST-NEUTRON RADIATION-THERAPY IN TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK - RESULTS OF AN RTOG PHASE-III RANDOMIZED STUDY
    GRIFFIN, TW
    DAVIS, RB
    LARAMORE, GE
    MAOR, MH
    HENDRICKSON, FR
    RODRIGUEZANTUNEZ, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (02): : 110 - 110
  • [49] Phase 2 Study of Docetaxel, Cisplatin, and Concurrent Radiation for Technically Resectable Stage III-IV Squamous Cell Carcinoma of the Head and Neck Reply
    Inohara, Hidenori
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (02): : 470 - 471
  • [50] Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: Impact of changing disease epidemiology on contemporary trial design
    Rodriguez, Cristina P.
    Adelstein, David J.
    Rybicki, Lisa A.
    Savvides, Panayiotis
    Saxton, Jerrold P.
    Koyfman, Shlomo A.
    Greskovich, John F.
    Yao, Min
    Scharpf, Joseph
    Lavertu, Pierre
    Wood, Benjamin G.
    Burkey, Brian B.
    Lorenz, Robert R.
    Rezaee, Rod P.
    Zender, Chad A.
    Ives, Denise I.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (11): : 1583 - 1589
12345